ResMed Shares Are Trading Lower After Rival Eli Lilly Received Approval for Zepbound as an Obstructive Sleep Apnea Treatment for Obese Adults.
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
J.P. Morgan's Top Healthcare Stocks for 2025
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
UBS's Global Equity Focus List: Stocks Within Health Technology
Behind the Scenes of Intuitive Surgical's Latest Options Trends
Boston Sci Issues Safety Recall for POLARx Cryoablation Catheters
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Least Shorted S&P 500 Stocks in November
Stryker Analyst Ratings
Medtronic Analyst Ratings
Intuitive Surgical Analyst Ratings
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today